Surmodics SRDX reported its Q3 earnings results on Wednesday, July 27, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Surmodics beat estimated earnings by 10.53%, reporting an EPS of $-0.34 versus an estimate of $-0.38.
Revenue was up $981 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.12 which was followed by a 0.4% drop in the share price the next day.
Here's a look at Surmodics's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | -0.34 | -0.31 | -0.25 | -0.17 |
EPS Actual | -0.22 | -0.13 | -0.10 | -0.17 |
Revenue Estimate | 23.97M | 23.71M | 23.06M | 23.31M |
Revenue Actual | 26.11M | 23.00M | 23.97M | 23.87M |
To track all earnings releases for Surmodics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.